|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,406.50 DKK | +3.34% |
|
+3.15% | -5.76% |
| 07-16 | Genmab A/S Announces Sales Results of Darzalex for Second Quarter of 2025 | CI |
| 07-16 | Genmab says net sales of Darzalex in Q2 $3,539 mln | RE |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | +3.34% | +3.15% | -5.76% | -22.25% | -39.87% | 13.02B |  | |  |
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition